CombiGene’s Senior Program Director Alvar Grönberg recently visited 4th Gene Therapy for Neurological Disorders Europe in Amsterdam. Here is a short summary:
At the conference, many interesting talks were given, covering a range of topics from how to achieve cell specific gene transcription to payer’s expectations regarding gene therapy products. The conference gave a good update of the field and a possibility to interact with people from academia and from other companies.